S.26.03 Potential role of amyloid imaging in mild cognitive impairment in Parkinson's disease von Villemagne, V.L

Volltext

Prognostic serum miRNA biomarkers associated with Alzheimer’s disease shows concordance with neuropsychological and neuroimaging assessment von Cheng, L, Doecke, J D, Sharples, R A, Villemagne, V L, Fowler, C J, Rembach, A, Martins, R N, Rowe, C C, Macaulay, S L, Masters, C L, Hill, A F

Volltext

Accelerated cortical atrophy in cognitively normal elderly with high β-amyloid deposition von CHETELAT, G, VILLEMAGNE, V. L, VILLAIN, N, JONES, G, ELLIS, K. A, AMES, D, MARTINS, R. N, MASTERS, C. L, ROWE, C. C

Volltext

Physical activity and amyloid-β plasma and brain levels: results from the Australian Imaging, Biomarkers and Lifestyle Study of Ageing von Brown, B M, Peiffer, J J, Taddei, K, Lui, J K, Laws, S M, Gupta, V B, Taddei, T, Ward, V K, Rodrigues, M A, Burnham, S, Rainey-Smith, S R, Villemagne, V L, Bush, A, Ellis, K A, Masters, C L, Ames, D, Macaulay, S L, Szoeke, C, Rowe, C C, Martins, R N

Volltext

APOE and BDNF polymorphisms moderate amyloid β-related cognitive decline in preclinical Alzheimer’s disease von Lim, Y Y, Villemagne, V L, Laws, S M, Pietrzak, R H, Snyder, P J, Ames, D, Ellis, K A, Harrington, K, Rembach, A, Martins, R N, Rowe, C C, Masters, C L, Maruff, P

Volltext

A blood-based predictor for neocortical Aβ burden in Alzheimer’s disease: results from the AIBL study von Burnham, S C, Faux, N G, Wilson, W, Laws, S M, Ames, D, Bedo, J, Bush, A I, Doecke, J D, Ellis, K A, Head, R, Jones, G, Kiiveri, H, Martins, R N, Rembach, A, Rowe, C C, Salvado, O, Macaulay, S L, Masters, C L, Villemagne, V L

Volltext

Cerebral microhemorrhage and brain β-amyloid in aging and Alzheimer disease von YATES, P. A, SIRISRIRO, R, VILLEMAGNE, V. L, FARQUHARSON, S, MASTERS, C. L, ROWE, C. C

Volltext

Plasma apolipoprotein E and Alzheimer disease risk: The AIBL study of aging von GUPTA, V. B, LAWS, S. M, TADDEI, K, MARTINS, R. N, VILLEMAGNE, V. L, AMES, D, BUSH, A. I, ELLIS, K. A, LUI, J. K, MASTERS, C, ROWE, C. C, SZOEKE, C

Volltext

Associations between gonadotropins, testosterone and β amyloid in men at risk of Alzheimer’s disease von Verdile, G, Laws, S M, Henley, D, Ames, D, Bush, A I, Ellis, K A, Faux, N G, Gupta, V B, Li, Q-X, Masters, C L, Pike, K E, Rowe, C C, Szoeke, C, Taddei, K, Villemagne, V L, Martins, R N

Volltext

Constructing longitudinal disease progression curves using sparse, short‐term individual data with an application to Alzheimer's disease von Budgeon, C.A., Murray, K., Turlach, B.A., Baker, S., Villemagne, V.L., Burnham, S.C.

Volltext

Aβ deposits in older non-demented individuals with cognitive decline are indicative of preclinical Alzheimer's disease von Villemagne, V.L., Pike, K.E., Darby, D., Maruff, P., Savage, G., Ng, S., Ackermann, U., Cowie, T.F., Currie, J., Chan, S.G., Jones, G., Tochon-Danguy, H., O’Keefe, G., Masters, C.L., Rowe, C.C.

Volltext

IN54-TH-01 Biomarkers for Alzheimer's disease from large cohort studies von Milner, A, Ellis, K.A, Bush, A.I, Masters, C.L, De Fazio, D, Foster, J, Hudson, P, Lautenschlager, N.T, Lenzo, N, Martins, R.N, Pike, K, Rowe, C.C, Savage, G, Szoeke, C, Taddei, K, Villemagne, V.L, Woodward, M, Darby, D, Ames, D

Volltext

Cross-Sectional and Longitudinal Comparison of Tau Imaging with 18F-MK6240 and 18F-Flortaucipir in Populations Matched for Age, MMSE and Brain Beta-Amyloid Burden von Bourgeat, Pierrick, Krishnadas, N., Doré, V., Mulligan, R., Tyrrell, R., Bozinovski, S., Huang, K., Fripp, J., Villemagne, V. L., Rowe, C. C.

Volltext

Application of the NIA-AA Research Framework: Towards a Biological Definition of Alzheimer’s Disease using Cerebrospinal Fluid Biomarkers in the AIBL Study von Burnham, Samantha C., Coloma, P. M., Li, Q.-X., Collins, S., Savage, G., Laws, S., Doecke, J., Maruff, P., Martins, R. N., Ames, D., Rowe, C. C., Masters, C. L., Villemagne, V. L.

Volltext

Two-Year Prognostic Utility of Plasma p217+tau across the Alzheimer’s Continuum von Feizpour, A., Doré, V., Doecke, J. D., Saad, Z. S., Triana-Baltzer, G., Slemmon, R., Maruff, P., Krishnadas, N., Bourgeat, P., Huang, K., Fowler, C., Rainey-Smith, S. R., Bush, A. I., Ward, L., Robertson, J., Martins, R. N., Masters, C. L., Villemagne, V. L., Fripp, J., Kolb, H. C., Rowe, Christopher C.

Volltext

Relationship between nicotinic receptors and cognitive function in early Alzheimer’s disease: A 2-[ 18F]fluoro-A-85380 PET study von Ellis, J.R., Villemagne, V.L., Nathan, P.J., Mulligan, R.S., Gong, S.J., Chan, J.G., Sachinidis, J., O’Keefe, G.J., Pathmaraj, K., Wesnes, K.A., Savage, G., Rowe, C.C.

Volltext

The relationship between nicotinic receptors and cognitive functioning in healthy aging: An in vivo positron emission tomography (PET) study with 2-[18F]fluoro-A-85380 von Ellis, J.R., Nathan, P.J., Villemagne, V.L., Mulligan, R.S., Ellis, K.A., Tochon-Danguy, H.J., Chan, J.G., O'keefe, G.J., Bradley, J., Savage, G., Rowe, C.C.

Volltext

II.P13 Amyloid load in Parkinson's Disease Dementia (PDD) and Lewy Body Dementia (LBD) measured with 11C-PIB PET von Edison, P., Rowe, C.C., Ahmed, I., Villemagne, V.L., Rinne, J., Brooks, D.J.

Volltext

Multicenter 18F-PI-2620 PET for in vivo Braak staging of tau pathology in Alzheimer’s disease von Rullmann, M, Brendel, M, Schroeter, M.L, Saur, D, Levin, J, Perneczky, R.G, Tiepolt, S, Patt, M, Mueller, A, Villemagne, V.L, Classen, J, Stephens, A.W, Sabri, O, Barthel, H

Volltext bestellen

La Lunga Attesa: Towards a Molecular Approach to Neuroimaging and Therapeutics in Alzheimer's Disease von Villemagne, V.L., Ng, S., Cappai, R., Barnham, K.J., Fodero-Tavoletti, M.T., Rowe, C.C., Masters, C.L.

Volltext